Northern Trust Corp Axogen, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Axogen, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 377,289 shares of AXGN stock, worth $5.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
377,289
Previous 365,337 3.27%
Holding current value
$5.9 Million
Previous $2.65 Million 99.96%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$7.52 - $14.69 $89,879 - $175,574
11,952 Added 3.27%
377,289 $5.29 Million
Q2 2024

Aug 14, 2024
SELL
$5.67 - $8.06 $70,444 - $100,137
-12,424 Reduced 3.29%
365,337 $2.65 Million
Q1 2024

May 14, 2024
SELL
$6.63 - $10.69 $30,040 - $48,436
-4,531 Reduced 1.19%
377,761 $3.05 Million
Q4 2023

Feb 13, 2024
SELL
$3.61 - $7.76 $87,694 - $188,505
-24,292 Reduced 5.97%
382,292 $2.61 Million
Q3 2023

Nov 13, 2023
BUY
$4.68 - $9.26 $35,422 - $70,088
7,569 Added 1.9%
406,584 $2.03 Million
Q2 2023

Aug 11, 2023
BUY
$8.5 - $10.38 $78,582 - $95,963
9,245 Added 2.37%
399,015 $3.64 Million
Q1 2023

May 15, 2023
BUY
$7.53 - $10.95 $20,669 - $30,057
2,745 Added 0.71%
389,770 $3.68 Million
Q4 2022

Feb 13, 2023
BUY
$9.44 - $13.09 $201,742 - $279,746
21,371 Added 5.84%
387,025 $3.86 Million
Q3 2022

Nov 14, 2022
SELL
$8.14 - $12.25 $57,598 - $86,681
-7,076 Reduced 1.9%
365,654 $4.36 Million
Q2 2022

Aug 12, 2022
SELL
$6.99 - $10.0 $285,345 - $408,220
-40,822 Reduced 9.87%
372,730 $3.05 Million
Q1 2022

May 13, 2022
SELL
$7.26 - $10.7 $82,764 - $121,979
-11,400 Reduced 2.68%
413,552 $3.28 Million
Q4 2021

Feb 08, 2022
SELL
$8.8 - $16.0 $15,998 - $29,088
-1,818 Reduced 0.43%
424,952 $3.98 Million
Q3 2021

Nov 15, 2021
SELL
$15.23 - $21.72 $84,952 - $121,154
-5,578 Reduced 1.29%
426,770 $6.74 Million
Q2 2021

Aug 13, 2021
BUY
$17.8 - $23.5 $102,901 - $135,853
5,781 Added 1.36%
432,348 $9.34 Million
Q1 2021

May 12, 2021
SELL
$17.18 - $22.6 $472,037 - $620,957
-27,476 Reduced 6.05%
426,567 $8.64 Million
Q4 2020

Feb 11, 2021
SELL
$11.5 - $17.96 $160,206 - $250,200
-13,931 Reduced 2.98%
454,043 $8.13 Million
Q3 2020

Nov 16, 2020
SELL
$10.62 - $13.12 $270,427 - $334,087
-25,464 Reduced 5.16%
467,974 $5.44 Million
Q2 2020

Aug 14, 2020
BUY
$7.35 - $10.81 $363,501 - $534,619
49,456 Added 11.14%
493,438 $4.56 Million
Q1 2020

May 14, 2020
BUY
$8.38 - $17.34 $37,710 - $78,030
4,500 Added 1.02%
443,982 $4.62 Million
Q4 2019

Feb 14, 2020
SELL
$11.18 - $18.6 $506,610 - $842,840
-45,314 Reduced 9.35%
439,482 $7.86 Million
Q3 2019

Nov 13, 2019
BUY
$12.09 - $20.46 $815,059 - $1.38 Million
67,416 Added 16.15%
484,796 $6.05 Million
Q2 2019

Aug 13, 2019
BUY
$18.5 - $25.47 $20,646 - $28,424
1,116 Added 0.27%
417,380 $8.27 Million
Q1 2019

May 13, 2019
BUY
$14.62 - $22.13 $41,491 - $62,804
2,838 Added 0.69%
416,264 $8.77 Million
Q4 2018

Feb 12, 2019
SELL
$17.09 - $38.25 $56,960 - $127,487
-3,333 Reduced 0.8%
413,426 $8.45 Million
Q3 2018

Nov 14, 2018
BUY
$34.05 - $55.9 $616,577 - $1.01 Million
18,108 Added 4.54%
416,759 $15.4 Million
Q2 2018

Sep 18, 2018
SELL
$36.15 - $52.5 $30,619 - $44,467
-847 Reduced 0.21%
398,651 $20 Million
Q2 2018

Aug 14, 2018
BUY
$36.15 - $52.5 $2.41 Million - $3.5 Million
66,654 Added 20.03%
399,498 $20.1 Million
Q1 2018

May 09, 2018
BUY
$24.4 - $40.25 $40,235 - $66,372
1,649 Added 0.5%
332,844 $12.1 Million
Q4 2017

Feb 14, 2018
BUY
$18.5 - $28.6 $436,785 - $675,246
23,610 Added 7.68%
331,195 $9.37 Million
Q3 2017

Nov 13, 2017
BUY
$14.65 - $19.35 $4.51 Million - $5.95 Million
307,585
307,585 $5.95 Million

Others Institutions Holding AXGN

# of Institutions
162
Shares Held
36.6M
Call Options Held
230K
Put Options Held
400
View Full List

About Axogen, Inc.

AXGN Quotes by TradingView
  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email